Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Intimation Pursuant To Regulation 29, Regulation 50(1) And 60(2) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 We refer to our letter dated October 25, 2019 intimating about approval of the Composite Scheme of Arrangement by the Board of Directors of the Company. We wish to inform you that the Company has issued Non-Convertible Debentures ('NCDs') in January 2017 and September 2018. Pursuant to the terms of issue of NCDs, the Company had by letter dated November 15, 2019 sought No Objection Certificates from the NCD holders for the proposed Scheme. In response, the NCD holders have conveyed their willingness for early redemption of NCDs. We wish to inform you that the Capital Issue Committee shall, at its meeting scheduled to be held on Monday, December 30, 2019, consider to approve redemption of NCDs of the Company. Details of Record Date for redemption of NCDs and the date of redemption of NCDs are given in the enclosed disclosure.
11-12-2019
Bigul

Jubilant Life Sciences Ltd - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation of loss of share certificate under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
04-12-2019
Bigul

Jubilant Life Sciences Ltd - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation of loss of share certificate under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
27-11-2019
Bigul

Jubilant Life Sciences Ltd - 530019 - Update

 In continuation to our intimation of November 8, 2019, regarding order of Securities Appellate Tribunal ('SAT') dated November 7, 2019, we wish to inform you that the Company has paid the penalty of Rs. 5 Lac pursuant to the above SAT Order on November 22, 2019.
23-11-2019
Bigul

Jubilant Life Sciences Ltd - 530019 - Compliance Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

 In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended September 30, 2019.
21-11-2019
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Partial Early Redemption Of 4.875% Senior Notes Due 2021 By Jubilant Pharma Limited, Wholly-Owned Subsidiary Of The Company (A Company Incorporated Under The Laws Of Singapore)

 We refer to our intimation dated October 21, 2019 regarding the proposed early redemption of principal amount of US$100,000,000 out of US$300,000,000 4.875% Senior Notes due 2021 (the 'Notes') issued by our material wholly-owned subsidiary, Jubilant Pharma Limited (a company incorporated under the laws of Singapore) ('JPL'). Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that on November 20, 2019, JPL has redeemed the principal amount of US$100,000,000 on pro-rata basis out of US$300,000,000 Notes at a redemption price of 102.43750% together with the accrued interest till date.
21-11-2019
Bigul

Jubilant Life Sciences share price climbs 7% after China removes anti-dumping duty on pyridine imports

 Ministry of Commerce (MOFCOM), People's Republic of China announced that starting Thursday, the anti-dumping duties on pyridine imports from India and Japan will be withdrawn
21-11-2019
Bigul

Jubilant Life Sciences Ltd - 530019 - We Enclose A Communication Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 Jubilant Life Sciences Limited, an integrated global Pharmaceutical and Life Sciences Company, has announced that Ministry of Commerce (MOFCOM), People's Republic of China, vide an announcement dated today has decided to terminate the 17.6% anti-dumping duty on imported pyridine originating in India.
20-11-2019
Bigul

Jubilant Life Sciences Ltd - 530019 - Securities Appellate Tribunal Order

 Dear Sirs, We refer to our letter dated February 1, 2018 intimating that SEBI, by Adjudication Order dated January 31, 2018, had imposed a penalty of Rs. 10 Lac on each of Jubilant Life Sciences Limited, Jubilant Stock Holding Private Limited, Mr. Shyam Sunder Bhartia and Mr. Hari Shanker Bhartia (collectively referred to as the 'Parties'). By our letter dated April 25, 2018, we had intimated that the Parties had filed appeals on April 24, 2018 before the Securities Appellate Tribunal ('SAT'), Mumbai, against the SEBI Adjudication Order. We wish to inform you that SAT, by its Order dated November 7, 2019, has reduced the penalty on Jubilant Life Sciences Limited from Rs. 10 lac to Rs. 5 lac and has dismissed the appeals of Jubilant Stock Holding Private Limited, Mr. Shyam Sunder Bhartia and Mr. Hari Shanker Bhartia. This is for your information and records.
08-11-2019
Bigul

Jubilant Life Sciences Ltd - 530019 - Announcement under Regulation 30 (LODR)-Credit Rating

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that India Ratings and Research Private Limited has, by its letter dated November 4, 2019, assigned the ratings for various facilities of the Company as per the attached details. This is for your kind information and record.
05-11-2019
Next Page
Close

Let's Open Free Demat Account